Upgrade to SI Premium - Free Trial

Form 3 ZOOZ Strategy Ltd. For: Mar 18 Filed by: COHEN AVI

March 18, 2026 7:23 AM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
COHEN AVI
(Last) (First) (Middle)
C/O ZOOZ STRATEGY LTD.
4B HAMELACHA ST.
(Street)
LOD, 7152008
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026 		3. Issuer Name and Ticker or Trading Symbol
ZOOZ Strategy Ltd. [ ZOOZ ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 7,718,245 (1)
D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Share Option (right to buy) (2) 02/03/2033 Ordinary Shares 35,797 9.16 D
Share Option (right to buy) (2) 02/03/2033 Ordinary Shares 35,797 10.51 D
Share Option (right to buy) (2) 02/03/2033 Ordinary Shares 35,796 13.66 D
Explanation of Responses:
1. Includes 7,688,354 ordinary shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one of the Issuer's ordinary shares. 6,726,816 of the RSUs vest on the following schedule: 25% of the RSUs vest on September 30, 2026 with the remainder vesting in 36 equal monthly installments thereafter; and 961,538 of the RSUs fully vest on November 21, 2026, subject in each case to the continuous Service (as defined in the Issuer's 2015 Incentive Compensation Plan) of the holder through the applicable vesting date.
2. Fully vested and exercisable.
/s/ Avi Cohen 03/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Categories

SEC Filings